Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amylyx Pharmaceuticals (AMLX) Return on Assets (2022 - 2025)

Historic Return on Assets for Amylyx Pharmaceuticals (AMLX) over the last 4 years, with Q3 2025 value amounting to 0.53%.

  • Amylyx Pharmaceuticals' Return on Assets rose 3600.0% to 0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53%, marking a year-over-year increase of 3600.0%. This contributed to the annual value of 0.85% for FY2024, which is 9600.0% down from last year.
  • Latest data reveals that Amylyx Pharmaceuticals reported Return on Assets of 0.53% as of Q3 2025, which was up 3600.0% from 0.9% recorded in Q2 2025.
  • In the past 5 years, Amylyx Pharmaceuticals' Return on Assets registered a high of 0.1% during Q4 2023, and its lowest value of 1.36% during Q4 2024.
  • In the last 4 years, Amylyx Pharmaceuticals' Return on Assets had a median value of 0.61% in 2022 and averaged 0.58%.
  • Its Return on Assets has fluctuated over the past 5 years, first surged by 9100bps in 2023, then plummeted by -14600bps in 2024.
  • Over the past 4 years, Amylyx Pharmaceuticals' Return on Assets (Quarter) stood at 0.7% in 2022, then soared by 114bps to 0.1% in 2023, then plummeted by -1461bps to 1.36% in 2024, then soared by 61bps to 0.53% in 2025.
  • Its Return on Assets was 0.53% in Q3 2025, compared to 0.9% in Q2 2025 and 1.06% in Q1 2025.